392 related articles for article (PubMed ID: 12031849)
21. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.
Endres M; Laufs U; Huang Z; Nakamura T; Huang P; Moskowitz MA; Liao JK
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8880-5. PubMed ID: 9671773
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
Ikeda Y; Young LH; Lefer AM
J Cardiovasc Pharmacol; 2003 Apr; 41(4):649-56. PubMed ID: 12658068
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS.
Seker FB; Kilic U; Caglayan B; Ethemoglu MS; Caglayan AB; Ekimci N; Demirci S; Dogan A; Oztezcan S; Sahin F; Yilmaz B; Kilic E
Neuroscience; 2015 Jan; 284():349-359. PubMed ID: 25453767
[TBL] [Abstract][Full Text] [Related]
24. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
Laufs U; La Fata V; Plutzky J; Liao JK
Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
[TBL] [Abstract][Full Text] [Related]
26. Statin treatment and 3' polyadenylation of eNOS mRNA.
Kosmidou I; Moore JP; Weber M; Searles CD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
29. Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.
Otto A; Fontaine J; Tschirhart E; Fontaine D; Berkenboom G
Br J Pharmacol; 2006 Jun; 148(4):544-52. PubMed ID: 16633368
[TBL] [Abstract][Full Text] [Related]
30. [HMG-CoA reductase inhibitor and risk of stroke].
Endres M; Laufs U
Nervenarzt; 1998 Aug; 69(8):717-21. PubMed ID: 9757426
[TBL] [Abstract][Full Text] [Related]
31. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
[TBL] [Abstract][Full Text] [Related]
33. Withdrawal of statin treatment abrogates stroke protection in mice.
Gertz K; Laufs U; Lindauer U; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2003 Feb; 34(2):551-7. PubMed ID: 12574574
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
35. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.
Ma M; Uekawa K; Hasegawa Y; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kuratsu J; Kim-Mitsuyama S
Brain Res; 2013 Jun; 1519():87-94. PubMed ID: 23632378
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of rosuvastatin on ischemic brain injury and its mechanism.
Xing H; Sun S; Mei Y; Herman D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):667-9. PubMed ID: 17357484
[TBL] [Abstract][Full Text] [Related]
38. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage.
Sironi L; Cimino M; Guerrini U; Calvio AM; Lodetti B; Asdente M; Balduini W; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):322-7. PubMed ID: 12588778
[TBL] [Abstract][Full Text] [Related]
39. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
Wu N; Li W; Lv Y; Shu W; Jia D
Pharmazie; 2014 Sep; 69(9):704-8. PubMed ID: 25272944
[TBL] [Abstract][Full Text] [Related]
40. Agmatine inhibits matrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells.
Yang MZ; Mun CH; Choi YJ; Baik JH; Park KA; Lee WT; Lee JE
Neurol Res; 2007 Oct; 29(7):749-54. PubMed ID: 17588309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
